U.S. Moves Medical Cannabis to Schedule III, Stocks Swing on Limited Scope
The U.S. Department of Justice on April 23 immediately reclassified state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act, marking the most significant shift in federal drug policy in decades, though shares ...
